NIH ‘concerned’ about side effect in coronavirus vaccine trial  Los Angeles TimesView Full coverage on Google News
The U.S. NIH has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca's coronavirus vaccine trial.The NIH has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca's coronavirus vaccine trial.

NIH ‘concerned’ about side effect in coronavirus vaccine trial - Los Angeles Times

While the FDA weighs whether to resume its trial of AstraZeneca's COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to two months to wrap, one NIH officer said.While the FDA weighs whether to resume its trial of AstraZeneca's COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to two months to wrap, one NIH officer said.

NIH 'very concerned' about serious side effect in coronavirus vaccine trial | FiercePharma

US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.

US regulators are 'very concerned' about the side effects of AstraZeneca's vaccine | Daily Mail Online

Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators are continuing to investigate.Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators are continuing to investigate.

Feds ‘Very Concerned’ About AstraZeneca COVID-19 Vaccine Side Effect

The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural […]

Feds ‘very concerned’ about serious side effect in AstraZeneca’s Covid vaccine trial – Raw Story

Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators continue to investigate.Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators continue to investigate.

NIH and FDA Examine Serious Side Effect That Surfaced in COVID Vaccine Trial - WebMD